Summary
Plants have emerged in the past decade as a suitable alternative to the current production systems for recombinant pharmaceutical proteins and, today their potential for low-cost production of high quality, much safer and biologically active mammalian proteins is largely documented.
Among various plant expression systems being explored, genetically modified suspension-cultured plant cells offer a promising system for production of biopharmaceuticals. Indeed, when compared to other plant-based production platforms that have been explored, suspension-cultured plant cells have the advantage of being totally devoid of problems associated with the vagaries of weather, pest, soil and gene flow in the environment. Because of short growth cycles, the timescale needed for the production of recombinant proteins in plant cell culture can be counted in days or weeks after transformation compared to months needed for the production in transgenic plants. Moreover, recovery and purification of recombinant proteins from plant biomass is an expensive and technically challenging business that may amount to 80–94% of the final product cost. One additional advantage of plant cell culture is that the recombinant protein fused with a signal sequence can be expressed and secreted into the culture medium, and therefore recovered and purified in the absence of large quantities of contaminating proteins. Consequently, the downstream processing of proteins extracted from plant cell culture medium is less expensive, which may/does balance the higher costs of fermentation. When needed for clinical use, recombinant proteins are easily produced in suspension-cultured plant cells under certified, controllable and sterile conditions that offer improved safety and provide advantages for good manufacturing practices and regulatory compliance.
In this chapter, we present basic protocols for rapid generation of transgenic suspension-cultured cells of Nicotiana tabacum, Oriza sativa and Arabidopis thaliana. These systems are powerful tools for plant-made pharmaceuticals production in highly controlled conditions.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Gomord, V., Sourrouille, C., Fitchette, A.C., Bardor, M., Pagny, S., Lerouge, P., and Faye, L. (2004) Production and glyco-sylation of plant made pharmaceuticals: the antibodies as a challenge. Plant Biotechnol. J. 2, 83–100.
Ma, J.K., Chikwamba, R., Sparrow, P., Fischer, R., Mahoney, R., and Twyman, R.M. (2005) Plant-derived pharmaceuti-cals—the road forward. Trends Plant Sci. 10, 580–585.
Ko, K., and Koprowski, H. (2005) Plant biopharming of monoclonal antibodies. Virus Res. 111, 93–100.
Schillberg, S., Twyman, R.M., and Fischer, R. (2005) Opportunities for recombinant antigen and antibody expression in trans-genic plants—technology assessment. Vaccine. 23, 1764–1769.
Gomord, V., Chamberlain, P., Jefferis, R., and Faye, L. (2005) Biopharmaceutical production in plants: problems, solutions and opportunities. Trends Biotechnol. 23, 559–565.
Faye, L., and Daniell, H. (2006) Pathway and freeways for protein import in the higher plant chloroplasts. Plant Biotechnol. J. 4, 275–279.
Sethuraman, N., and Stadheim, T.A. (2006) Challenges in therapeutic glycoprotein production. Curr. Opin. Biotechnol. 17, 341–346.
Gomord, V., and Faye, L. (2004) Post-translational modifications of therapeutic proteins in plants. Curr. Opin. Plant Biol. 7, 171–181.
Walsh, G., and Jefferis, R. (2006) Post-translational modifications in the context of therapeutic proteins. Nat. Biotechnol. 24, 1241–1252.
Merle, C., Perret, S., Lacour, T., Jonval, V., Hudaverdian, S., Garrone, R., Ruggiero, F., and Theisen, M. (2002) Hydroxylated human homotrimeric collagen I in Agro-bacterium tumefaciens-mediated transient expression and in transgenic tobacco plant. FEBS Lett. 515, 114–118.
Theisen, M. (1999) Production of recom-binant blood factors in transgenic plants. Adv. Exp. Med. Biol. 464, 211–220.
Ma, J.K.C., Hiatt, A., Hain, M., Vine, N.D., Wang, F., Stabila, P., van Dolleweerd, C., Mostov, K., and Lherner, T. (1995) Generation and assembly of secretory antibodies in plants. Science 268, 716–719.
Kieran, P.M., MacLoughlin, P. F., and Malone, D.M. (1997) Plant cell suspension cultures: some engineering considerations. J. Biotechnol. 59, 39–52.
Fischer, R., Emans, N., Schuster, F., Hellwig, S., and Drossard, J. (1999) Towards molecular farming in the future: using plant-cell-suspension cultures as bioreactors. Bio-technol. Appl. Biochem. 30, 109–12.
Doran, P.M. (2000) Foreign protein production in plant tissue cultures. Curr. Opin. Biotechnol. 11, 199–204.
Honda, G., Sakakibara, F., Yazaki, K., and Tabata, M. (1988) Isolation of deoxy-shikonin, an antidermatophytic principle from Lithospermum erythrorhizon cell cultures. J. Nat. Prod. 51, 152–154.
Drapeau, D., Sauvaire, Y., Blanch, H.W., and Wilke, C.R. (1986) Improvement of dios-genin yield from Dioscorea deltoidea plant cell cultures by use of a non-traditional hydrolysis method. Planta Med. 52, 474–478.
Seki, M., Ohzora, C., Takeda, M., and Furusaki, S. (2000) Taxol (paclitaxel) production using free and immobilized cells of Taxus cuspidate. Biotechnol. Bioeng. 53, 214–219.
Sijmons, P.C., Dekker, B.M., Schrammeijer, B., Verwoerd, T.C., van den Elzen, P.J., and Hoekema, A. (1990) Production of correctly processed serum albumin in trans-genic plants. Bio/Technology. 8, 217–221.
Fischer, R., and Emans, N. (2000) Molecular farming of pharmaceutical proteins. Transgenic Res. 9, 279–99.
Kusnadi, A.R., Nikolov, Z.L., and Howard, J.A. (2000) Production of recombinant proteins in transgenic plants: practical considerations. Biotechnol. Bioeng. 56, 473–484.
Evangelista, R.L., Kusnadi, A.R., Howard, J.A., and Nikolov, Z.L. (1998) Process and economic evaluation of the extraction and purification of recombinant β -glucuronidase from transgenic corn. Biotechnol. Prog. 14, 607–614.
Firek, S., Draper, J., Owen, M.R.L., Gandecha, A., Cockburn, B., and Whitelam, G.C. (1993) Secretion of a functional single-chain Fv protein in transgenic tobacco plants and cell suspension cultures. Plant Mol. Biol. 23, 861–870.
Magnuson, N.S., Linzmaier, P.M., Reeves, R., An, G., HayGlass, K., and Lee, J.M. (1998) Secretion of biologically active human interleukin-2 and interleukin-4 from genetically modified tobacco cells in suspension culture. Protein Expr. Purif. 13, 45–52.
James, E.A., Wang, C., Wang, Z., Reeves, R., Shin, J.H., Magnuson, N.S., and Lee, J.M. (2000) Production and characterization of biologically active human GM-CSF secreted by genetically modified plant cells. Protein Expr. Purif. 19, 131–138.
Kwon, T.H., Seo, J.E., Kim, J., Lee, J.H., Jang, Y.S., and Yang, M.S. (2003) Expression and secretion of the heterodimeric protein interleukin-12 in plant cell suspension culture. Biotechnol. Bioeng. 81, 870–875.
Sunil Kumar, G.B., Ganapathi, T.R., Revathi, C.J., Prasad, K.S., and Bapat, V.A. (2003) Expression of hepatitis B surface antigen in tobacco cell suspension cultures. Protein Expr. Purif. 32, 10–17.
Reggi, S., Marchetti, S., Patti, T., De Ami- cis, F., Cariati, R., Bembi, B., and Fogher, C. (2005) Recombinant human acid beta-glucosidase stored in tobacco seed is stable, active and taken up by human fibroblasts. Plant Mol. Biol. 57, 101–113.
Cramer, C.L., Weissenborn, D.L., Oishi, K.K., Grabau, E.A., Bennett, S., Ponce, E., Grabowski, G.A., and Radin, D.N. (1996) Bioproduction of human enzymes in trans-genic tobacco. Ann. NY Acad. Sci. 792, 62–71.
Lienard, D., Tran Dinh, O., van Oort, E., Van Overtvelt, L., Bonneau, C., Wambre, E., Bardor, M., Cosette, P., Didier-Laurent, A., de Borne, F.D., Delon, R., van Ree, R., Moingeon, P., Faye, L., and Gomord, V. (2007) Suspension-cultured BY-2 tobacco cells produce and mature immunologically active house dust mite allergens. Plant Bio-technol. J. 5, 93–108.
Nebenfuhr, A., Gallagher, L.A., Dunahay, T.G., Frohlick, J.A., Mazurkiewicz, A.M., Meehl, J.B., and Staehelin, L.A. (1999) Stop-and-go movements of plant Golgi stacks are mediated by the acto-myosin system. Plant Physiol. 121, 1127–42.
Jefferson, R.A., Burgess, S.M., and Hirsch, D. (1986) P-Glucuronidase from Escherichia coli as a gene-fusion marker. Proc. Natl. Acad. Sci. USA. 83, 8447–8451.
Jefferson, R.A., Kavanagh, T.A., and Bevan, M.W. (1987) GUS fusions: P-glucuronidase as a sensitive and versatile gene fusion marker in higher plants. EMBO J. 6, 3901–3907.
Hooykaas, P.J.J., and Schilperoort, R.A. (1992) Agrobacterium and plant genetic engineering. Plant Mol. Biol. 19, 15–38.
Pagny, S., Bouissonnié, F., Sarkar, M., Fol- let-Gueye, M.L., Driouich, A., Schachter, H., Faye, L., and Gomord, V. (2003) Structural requirements for Arabidopsis beta 1,2 xylosyltransferase activity and targeting to the Golgi. Plant J. 33, 189–203.
Laemmli, U. (1970) Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 227, 680–685.
Towbin, H., Staehelin, T., and Gordon, J. (1979) Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc. Natl. Acad. Sci. USA. 76, 4350–4354.
Höfgen, R., and Willmitzer, L. (1988) Storage of competent cells for Agrobacterium transformation. Nucleic Acids Res. 16, 9877.
Hiei, Y., Komari, T., and Kubo, T. (1997) Transformation of rice mediated by Agro-bacterium tumefaciens. Plant Mol. Biol. 35, 205–218.
Hoque, M.E., Mansfield, J.W., and Bennett, M.H. (2005) Agrobacterium -mediated transformation of Indica rice genotypes: an assessment of factors affecting the transformation efficiency. Plant Cell Tiss. Organ Cult. 82, 45–55.
Faye, L., Gomord, V., Lainé, A.-C., and Chrispeels, M.J. (1993) Affinity purification of antibodies specific for Asn-linked glycans containing a l,3 fucose or β l,2 xylose. Anal. Biochem. 209, 104–108.
Saint-Jore-Dupas, C., Nebenführ, A., Bou- laflous, A., Follet-Gueye, M.L., Plasson, C., Hawes, C., Driouich, A., Faye, L., and Gomord, V. (2006) Plant N- glycan processing enzymes employ different targeting mechanisms for their spatial arrangement along the secretory pathway. Plant Cell. 18, 3182–3200.
Gomord, V., Denmat, L.A., Fitchette-Lainé, A.-C., Satiat-Jeunemaitre, B., Hawes, C., and Faye, L. (1997) The C-terminal HDEL sequence is sufficient for retention of secretory proteins in the endoplasmic reticulum but promotes vacuolar targeting of proteins that escape the endoplasmic reticulum. Plant J. 11, 101–103.
Downing, W.L., Galpin, J.D., Clemens, S., Lauzon, S.M., Samuels, A.L., Pidkowich, M.S., Lorne Clarke, A., and Kermode, A.R. (2006) Synthesis of enzymatically active human a - l -iduronidase in Arabidopsis cgl (complex glycan-deficient) seeds. Plant Bio-technol. J. 4, 169–181.
Tyagi, A.K., and Mohanty, A.K. (2000) Rice transformation for crop improvement and functional genomics. Plant Sci. 158, 1–18.
Huang, L.F., Liu, Y.K., Lu, C.A., Hsieh, S.L., and Yu, S.M. (2005) Production of human serum albumin by sugar starvation induced promoter and rice cell culture. Transgenic Res. 14, 569–581.
Takaiwa, F., Takagi, H., Hirose, S., and Wakasa, Y. (2007) Endosperm tissue is good production platform for artificial recom- binant proteins in transgenic rice. Plant Bio-technol. J. 5, 84–92
Enfors, S.O. (1992) Control of in vivo pro- teolysis in the production of recombinant proteins. Trends Biotechnol. 10, 310–315.
Shin, Y.J., Hong, S.Y., Kwon, T.H., Jang, Y.S., and Yang, M.S. (2003) High level of expression of recombinant human granulo-cyte-macrophage colony stimulating factor in transgenic rice cell suspension culture. Biotechnol. Bioeng. 82, 778–783.
Acknowledgments
Work on plant-made pharmaceuticals at the University of Rouen was supported by the Centre National de la Recherche Scientifique (CNRS) and by the “Ministère de la Recherche”. This study was also partially supported by a grant from the “laboratoire P. Fabre”, France. We thank present and former colleagues who contributed to the work described in this review and we also thank L. Faye and A.-C. Fitchette for critical reading of the manuscript.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2009 Springer Science+Business Media, LLC
About this protocol
Cite this protocol
Plasson, C. et al. (2009). Production of Recombinant Proteins in Suspension–Cultured Plant Cells. In: Faye, L., Gomord, V. (eds) Recombinant Proteins From Plants. Methods in Molecular Biology™, vol 483. Humana Press. https://doi.org/10.1007/978-1-59745-407-0_9
Download citation
DOI: https://doi.org/10.1007/978-1-59745-407-0_9
Publisher Name: Humana Press
Print ISBN: 978-1-58829-978-9
Online ISBN: 978-1-59745-407-0
eBook Packages: Springer Protocols